I

Ilyang Pharmaceutical Co Ltd
KRX:007570

Watchlist Manager
Ilyang Pharmaceutical Co Ltd
KRX:007570
Watchlist
Price: 13 050 KRW
Market Cap: 254.9B KRW

Intrinsic Value

The intrinsic value of one Ilyang Pharmaceutical Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 13 050 KRW, Ilyang Pharmaceutical Co Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Ilyang Pharmaceutical Co Ltd Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Ilyang Pharmaceutical Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Ilyang Pharmaceutical Co Ltd looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether Ilyang Pharmaceutical Co Ltd usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Ilyang Pharmaceutical Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Ilyang Pharmaceutical Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Ilyang Pharmaceutical Co Ltd.

Explain Valuation
Compare Ilyang Pharmaceutical Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Ilyang Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Ilyang Pharmaceutical Co Ltd

Current Assets 139.8B
Cash & Short-Term Investments 15.6B
Receivables 47.4B
Other Current Assets 76.8B
Non-Current Assets 305B
Long-Term Investments 61.1B
PP&E 218B
Intangibles 25.4B
Other Non-Current Assets 511.2m
Current Liabilities 160.3B
Accounts Payable 26.3B
Accrued Liabilities 445.2m
Short-Term Debt 91.8B
Other Current Liabilities 41.6B
Non-Current Liabilities 48.9B
Long-Term Debt 28.6B
Other Non-Current Liabilities 20.3B
Efficiency

Free Cash Flow Analysis
Ilyang Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Ilyang Pharmaceutical Co Ltd

Revenue
232.3B KRW
Cost of Revenue
-152.8B KRW
Gross Profit
79.5B KRW
Operating Expenses
-69.5B KRW
Operating Income
10B KRW
Other Expenses
895.9m KRW
Net Income
10.9B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

Ilyang Pharmaceutical Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Sustainable 3Y Average Gross Margin
Healthy Gross Margin
Declining Net Margin
Low 3Y Average Operating Margin
hidden
Profitability
Score

Ilyang Pharmaceutical Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Ilyang Pharmaceutical Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
hidden
Solvency
Score

Ilyang Pharmaceutical Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Ilyang Pharmaceutical Co Ltd

There are no price targets for Ilyang Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Ilyang Pharmaceutical Co Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Ilyang Pharmaceutical Co Ltd stock?

The intrinsic value of one Ilyang Pharmaceutical Co Ltd stock under the Base Case scenario is hidden KRW.

Is Ilyang Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 13 050 KRW, Ilyang Pharmaceutical Co Ltd is hidden .

Back to Top